Top Stories
-
Ten Columbia research teams have received a Life Science Accelerator Pilot Grant for their novel, out-of-the-box ideas for translational research.
Topic
-
Which patients respond less well to radiation therapy and why? Find out how the Spina lab is approaching this problem from the perspective of the immune system.
Topic
-
Source:
CUIMC NewsroomAngela Christiano's groundbreaking research in alopecia areata led to the first FDA-approved systemic treatment for the autoimmune disease, and could also point the way to new cancer therapies.
Topic
-
Annual Precision Medicine Pilot Grants are awarded to five Columbia research teams, including research led by members Drs. Brent Stockwell and Kelley Yan.
Topic
Latest News
-
Source:
Columbia NewsJune 15, 2022"In the next wave of precision medicine, treating cancer will depend on our ability to be even more predictive with our approaches," writes Dr. Andrea Califano in our latest Disruptors column.
Topic
-
Source:
Columbia EngineeringMay 2, 2022Researchers have developed a multi-organ chip, a novel platform that captures the biology of organ interactions in the body, enabling a new way to study disease progression and treatments.
Topic
- April 29, 2022
Expert geneticist Dr. Wendy Chung takes us through the ever-evolving genetics landscape and its revolutionary impact in cancer.
Topic
- January 16, 2022
Two research teams led by experts in oncology and engineering have won pilot grants from the Herbert Irving Comprehensive Cancer Center and Columbia Engineering.
Topic
- September 27, 2021
"Precision cancer medicine needs to be envisioned as understanding how cancer works, which goes far beyond individual gene mutations." Read Dr. Bass' Disruptors column for the HICCC.
Topic
- June 24, 2021
In our Disruptors column, Gordana Vunjak-Novakovic discusses groundbreaking work between engineers and cancer researchers to accelerate personalized therapeutics and better understand the disease.
Topic
- June 5, 2021
Results of a new phase 2 clinical trial demonstrate the potential of targeted therapy in combination with chemotherapy to treat patients with uterine leiomyosarcoma.
Topic
- June 3, 2021
Five teams of researchers are awarded pilot grants to conduct innovative basic science, translational, and clinical research across multiple diseases.
- May 11, 2021
In a new study by Adam Bass, MD, scientists have found that many esophageal cancers turn on ancient viral DNA embedded in our genome, a finding that could lead to improvements in immunotherapy.
Topic
-
Source:
CUIMC NewsroomOctober 29, 2020Adam Bass, MD, joins the HICCC as the founding director of the Center for Precision Cancer Medicine and director of gastrointestinal oncology.
